A proposal to redefine familial combined hyperlipidaemia - Third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European society for clinical investigation

European Journal of Clinical Investigation

Volumn 32, Issue 2, 2002, Pages 71-73

  Sniderman, A D ^a,h   Castro Cabezas, M ^b   Ribalta, Josep ^c,i   Carmena, R ^d   De Bruin, T W A ^e   De Graaf, J ^b,j   Erkelens, D W ^b   Humphries, S E ^f,g   Masana, L ^c,i   Real, J T ^d   Talmud, P J ^f   Taskinen, M R ^g  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^g UNIVERSITY OF HELSINKI   (Finland)

^h MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁱ HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSLIPIDEMIA; DYSLIPOPROTEINEMIA; FAMILIAL HYPERLIPEMIA; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEREDITY; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; MEDICAL RESEARCH; PHENOTYPE; PRIORITY JOURNAL; STANDARD; TRIACYLGLYCEROL BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

APOLIPOPROTEINS B; EUROPE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPOPROTEINS, LDL; PHENOTYPE; SOCIETIES, MEDICAL; SPAIN; TRIGLYCERIDES;

EID: 0037003046     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00941.x     Document Type: Conference Paper

References (9)

1. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-68.
2. Nikkila EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet 1973;1:954-9.
3. Rose HG, Kranz P, Weinstock M, Juliano J, Haft JI. Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. Am J Med 1973;54:148-60.
4. Grundy SM, Chait A, Brunzell JD. Familial Combined Hyperlipidemia workshop. Arteriosclerosis 1987;7:203-7.
5. Castro Cabezas M, De Bruin TWA, Erkelens DW. Familial Combined Hyperlipidemia 1973-91. Neth J Med 1992;40:83-95.
6. De Graaf J, Stalenhoef AFH. Defects of lipoprotein metabolism in familial combined hyperlipidemia. Curr Opin Lipidol 1998;9:189-96.
7. Albers JJ, Marcovina SM, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-1 and B. Comparability of apolipoprotein B values by use of International Reference Material. Clin Chem 1994;40:586-92.
8. Demacker PN, Veerkamp MJ, Bredie SJ, Marcovina S, de Graaf J, Stalenhoef AF. Comparison of the measurement of lipids and lipoproteins versus assay for apoliprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. Atherosclerosis 2000;153:483-90.
9. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol 1995;75:1189-95.